Dyne Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DYN research report →
Range $26 – $50
Price Chart
About the company
Dyne Therapeutics, Inc. is a U. S.
- CEO
- John G. Cox
- IPO
- 2020
- Employees
- 289
- HQ
- Waltham, MA, US
Get TickerSpark's AI analysis on DYN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.90B
- P/E
- -4.41
- Fwd P/E
- 82.01
- PEG
- 4.28
- P/S
- 0.00
- P/B
- 3.13
- EV/EBITDA
- -4.04
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -69.73%
- ROIC
- -52.77%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-2,049,000+8.6%
- Op Income
- $-468,184,000
- Net Income
- $-446,214,000-40.6%
- EPS
- $-3.47-3.0%
- OCF Growth
- -37.9%
- FCF Growth
- -37.4%
- 52W High
- $27.31
- 52W Low
- $14.00
- 50D MA
- $16.61
- 200D MA
- $19.28
- Beta
- 1.21
- RSI (14)
- 42
- Avg Volume
- 2.92M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Dynegy reported sharply higher first-quarter adjusted EBITDA on acquisition contributions and reaffirmed 2016 guidance, while moving ahead with coal retirements and an IPH restructuring review.· May 5, 2016
- Adjusted EBITDA rose to $251 million from $85 million a year ago, driven mainly by the EquiPower and Duke Midwest acquisitions.
- The company reaffirmed 2016 adjusted EBITDA guidance of $1 billion to $1.2 billion and free cash flow guidance of $200 million to $400 million.
- Dynegy plans to mothball Baldwin units 1 and 3 and Newton unit 2, retire Wood River in June 2016, and target an additional 500 MW for shutdown later this year.
- Management said the shutdowns should improve free cash flow by about $200 million over five years, with an additional roughly $100 million from Wood River.
- Dynegy is starting discussions with IPH debt holders to find a permanent fix, with outcomes ranging from a more sustainable structure to transferring ownership of Genco plants to the bondholders.
Adjusted EBITDA was $251 million in the first quarter, versus $85 million in the same period last year. Management said the increase was primarily due to a $209 million contribution from the EquiPower and Duke Midwest acquisitions. Dynegy reaffirmed full-year 2016 adjusted EBITDA guidance of $1 billion to $1.2 billion and free cash flow guidance of $200 million to $400 million. The company said it did not clear any of its 2,197 MW of unsold capacity in the MISO auction because the clearing price was below unit cost. For planned shutdowns, management estimated close to $200 million of free cash flow savings over five years from Baldwin and Newton, plus roughly $100 million from Wood River, and said the Newton scrubber could lift savings to north of $400 million if avoided.
Bob Flexon framed the quarter around portfolio rationalization and cash flow protection, saying Dynegy is no longer willing to rely on a capacity market that he считает structurally weak for Illinois competitive generators. He said the company is “taking matters into our own hands” by right-sizing the fleet to match retail and wholesale obligations, and emphasized that the mothballed units could potentially come back if market conditions changed. His tone was firm and skeptical on MISO reform and Illinois legislative relief, but constructive on preserving value through portfolio actions.
Clint Freeland focused on the financial impact of the shutdowns and the capital structure implications. He said the retiring units are slightly EBITDA negative over five years, but the real driver is capital spending, with about $160 million of the roughly $200 million free cash flow benefit tied to CapEx and the rest to EBITDA; Wood River adds about $100 million more. He also noted the company added $100 million of liquidity capacity at the Dynegy level and $25 million at the JV level through bank commitments that upsized the existing revolver, and explained that any move to bring IPH onto the balance sheet would require a very low debt load and confidence in free cash flow positivity.
Analysts pressed on the timing and scope of the additional 500 MW shutdowns, the Newton scrubber, and whether the company could avoid that spend if PJM commitments were shifted. Management said the final 500 MW decision is still pending and depends partly on whether commitments can be transferred, and that eliminating the scrubber could push five-year free cash flow savings to north of $400 million. Other questions focused on IPH restructuring, with management saying the first bondholder meeting is coming later this month and that outcomes range from the bondholders taking the plants to a balance-sheet consolidation if the debt is reduced enough. Analysts also asked about the value of PSA allocations and capacity commitments; management said the PSA is cancelable with six months’ notice, and that incremental PJM capacity positions can change quarter to quarter through auction true-ups.
The bullish case from this call is that Dynegy is actively reshaping the portfolio to improve free cash flow and reduce exposure to a capacity market management views as broken. The company still sees value in its coal fleet as a hedge against gas volatility, and management sounded confident that the retail business can absorb the uncommitted megawatts while newer acquisitions and core assets support earnings.
The main risks are the weak MISO market, continued unsold capacity, and the possibility that shutdowns and the IPH situation are symptoms of deeper structural stress. Management also flagged heavy uncertainty around the Newton scrubber, the California exit timeline, and the final outcome of the IPH debt negotiations, which could end in a transfer of assets to bondholders rather than a value-creating restructuring.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 82.1%
- Shares Outstanding
- 187.39M
- Float Shares
- 153.86M
of shares held by institutions
256 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 30.91M | ▲ 126.49K |
| Blackrock, Inc. | 14.47M | ▲ 2.07M |
| Janus Henderson Group Ltd. | 13.65M | ▼ 240.35K |
| Jupiter Topco LLC | 12.00M | ▲ 12.00M |
| Vanguard Group Inc | 11.22M | ▲ 1.46M |
| Fmr LLC | 11.15M | ▼ 60.63K |
| State Street Corp | 8.16M | ▲ 700.05K |
| Vanguard Capital Management LLC | 7.55M | ▲ 1.24M |
| Orbis Allan Gray Ltd | 7.01M | ▲ 244.31K |
| Vanguard Portfolio Management LLC | 4.69M | ▲ 643.24K |
| Tcg Crossover Management, LLC | 4.62M | 0 |
| Geode Capital Management, LLC | 4.40M | ▲ 652.95K |
Held by 304 ETFs
Biggest fund positions in DYN by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 13, 26 | Friedl-Naderer Johanna | sell | 231 |
| Nov 13, 26 | Kerr Douglas | sell | 2,604 |
| Nov 13, 26 | Lucera Erick | sell | 1,991 |
| Oct 20, 26 | Kerr Douglas | other | 8,000 |
| Oct 20, 26 | Kerr Douglas | other | 12,000 |
| Oct 2, 26 | Posner Brian S | buy | 2,500 |
| Sep 4, 26 | Friedl-Naderer Johanna | sell | 900 |
| Sep 8, 26 | Friedl-Naderer Johanna | sell | 185 |
| Sep 4, 26 | Kerr Douglas | sell | 3,745 |
| Sep 8, 26 | Kerr Douglas | sell | 1,290 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DYN coverage
Recent articles, reports, and earnings notes.
No research on DYN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DYN report →Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com · Nov 19
Dyne Therapeutics (NASDAQ:DYN) Share Price Breaks Below 50-Day Moving Average on Insider Selling
defenseworld.net · Nov 17
Dyne Therapeutics to Participate in Upcoming Investor Conference
globenewswire.com · Nov 11
Dyne Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com · Nov 5
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com · Oct 22
Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
globenewswire.com · Sep 29
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com · Sep 17
Dyne Therapeutics, Inc. (DYN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
seekingalpha.com · Sep 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.